Cytosorbents Corporation (CTSO) Earnings History
Net Loss21 years of earnings data (2005–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Cytosorbents Corporation (CTSO) Earnings Overview
As of June 23, 2026, Cytosorbents Corporation (CTSO) reported trailing twelve-month net income of -$12M, reflecting +65.8% year-over-year growth. The company earned $-0.19 per diluted share over the past four quarters, with a net profit margin of -22.1%.
Looking at the long-term picture, CTSO's historical earnings data spans multiple years. The company achieved its highest annual net income of -$80,000 in fiscal 2005.
Cytosorbents Corporation is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NVCR (-$173M net income, -20.8% margin), MASI ($76M net income, -9.9% margin), ICUI ($46M net income, 0.0% margin), CTSO has room to improve margins relative to the peer group. Compare CTSO vs NVCR →
CTSO Earnings vs Peers
Earnings metrics vs comparable public companies
CTSO Historical Earnings Data (2005–2025)
21 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$8M | +60.4% | -$14M | $-0.13 | -22.1% | -38.4% |
| 2024 | -$21M | +29.2% | -$16M | $-0.38 | -58.2% | -46.2% |
| 2023 | -$29M | +10.9% | -$32M | $-0.65 | -94.1% | -102.8% |
| 2022 | -$33M | -33.6% | -$32M | $-0.75 | -94.6% | -90.9% |
| 2021 | -$25M | -213.4% | -$23M | $-0.57 | -61.2% | -56.7% |
| 2020 | -$8M | +59.3% | -$10M | $-0.20 | -19.9% | -26.3% |
| 2019 | -$19M | -11.9% | -$19M | $-0.60 | -84.6% | -83.3% |
| 2018 | -$17M | -103.4% | -$16M | $-0.56 | -85.0% | -77.0% |
| 2017 | -$8M | +29.1% | -$10M | $-0.31 | -63.2% | -73.6% |
| 2016 | -$12M | -46.8% | -$11M | $-0.47 | -145.5% | -140.0% |
| 2015 | -$8M | +12.8% | -$9M | $-0.33 | -200.5% | -229.4% |
| 2014 | -$9M | -99.3% | -$7M | $-0.65 | -296.4% | -231.4% |
| 2013 | -$5M | -27.7% | -$5M | $-0.50 | -569.2% | -573.5% |
| 2012 | -$4M | +33.2% | -$3M | $-0.46 | -2417.0% | -2303.1% |
| 2011 | -$5M | -88.4% | -$4M | $-0.86 | -15193.9% | -12297.7% |
| 2010 | -$3M | -6.3% | -$3M | $-0.74 | - | - |
| 2009 | -$3M | +9.3% | -$2M | $-1.64 | - | - |
| 2008 | -$3M | +9.9% | -$3M | $-3.00 | - | - |
| 2007 | -$3M | +56.3% | -$3M | $-3.37 | - | - |
| 2006 | -$8M | -9489.5% | -$3M | $-7.87 | - | - |
| 2005 | $-80,000 | - | $-80,000 | $-0.26 | -800.0% | -800.0% |
Download Data
Export CTSO earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
21+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
CTSO — Frequently Asked Questions
Quick answers to the most common questions about buying CTSO stock.
What is CTSO earnings per share (EPS)?
CTSO trailing twelve-month (TTM) diluted EPS is $-0.19, reflecting +65.8% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2005 to 2025 is available in the table on this page.
What is Cytosorbents Corporation's net income?
Cytosorbents Corporation (CTSO) trailing twelve-month net income is $-12M as of 2025. Earnings grew +65.8% year-over-year.
Is CTSO profitable?
CTSO is not currently profitable on a TTM basis, reporting a net loss of $-12M. Net margin is -22.1%. Investors should monitor for a return to profitability.
What is CTSO's earnings growth rate?
CTSO compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2005 to 2025.
What are CTSO's profit margins?
Cytosorbents Corporation net profit margin is -22.1%, operating margin is -38.4%, and gross margin is +71.5%. Below-average margins reflect competitive or cost pressures. Return on Equity is -96.4%.
Is CTSO growing earnings?
Yes, CTSO earnings are accelerating — EPS growth of +65.8% exceeds the 5-year CAGR of N/A. TTM net income reached $-12M. Earnings momentum is strengthening.
What was CTSO's best earnings year?
Cytosorbents Corporation's highest annual net income on record is $-80000.00, achieved in fiscal year 2005. Earnings history on this page spans 2005 to 2025 and includes all annual and quarterly figures.
What were CTSO's earnings last quarter?
CTSO's most recent reported quarter was Q1 2026. Net income was $-5M with diluted EPS of $-0.08. For a full breakdown of all quarters, see the quarterly earnings table on this page.